Industry Research Reports

Home > Reports > Chemical & Material > Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-07

Pages: 109 Pages

Report ld: 3426645

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Nicotinamide Mononucleotide (NMN) Market Trends: at a CAGR of 13.4% during the forecast period

Nicotinamide Mononucleotide (NMN) Market Size(US$)

CAGR 2025-2031

13.4%

Market Size,2031

USD 992

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 468 million

Market Forecast in 2031(Value)

US$ 992 million

CAGR

13.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nicotinamide Mononucleotide (NMN) by region & country, by Type, and by Application.

The Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN).

MARKET SEGMENTATION

By Company

GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Content ≥98%
Content ＜98%

Segment by Application

Health Care Products
Cosmetics
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Nicotinamide Mononucleotide (NMN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Nicotinamide Mononucleotide (NMN) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Nicotinamide Mononucleotide (NMN) Product Introduction

1.2 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast

1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value (2020-2031)

1.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume (2020-2031)

1.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Price (2020-2031)

1.3 Nicotinamide Mononucleotide (NMN) Market Trends & Drivers

1.3.1 Nicotinamide Mononucleotide (NMN) Industry Trends

1.3.2 Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity

1.3.3 Nicotinamide Mononucleotide (NMN) Market Challenges

1.3.4 Nicotinamide Mononucleotide (NMN) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2024)

2.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)

2.3 Global Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2024)

2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company Players (2020-2025)

2.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025)

2.6 Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters

2.7 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Mononucleotide (NMN)

2.9 Nicotinamide Mononucleotide (NMN) Market Competitive Analysis

2.9.1 Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Mononucleotide (NMN) Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Content ≥98%

3.1.2 Content ＜98%

3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type

3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2020-2031)

3.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%) (2020-2031)

3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type

3.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2020-2031)

3.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%) (2020-2031)

3.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Health Care Products

4.1.2 Cosmetics

4.1.3 Others

4.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application

4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2020-2031)

4.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%) (2020-2031)

4.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application

4.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2020-2031)

4.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%) (2020-2031)

4.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region

5.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2020-2025)

5.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2026-2031)

5.1.4 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), (2020-2031)

5.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region

5.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2020-2025)

5.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2026-2031)

5.2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), (2020-2031)

5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

5.4.2 North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

5.5.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

5.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

5.7.2 South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

5.8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value

6.2.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.2.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.3.2 United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.4.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.5.2 China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.5.3 China Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.6.2 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.7.2 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.8.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031

6.9.2 India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

6.9.3 India Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 GeneHarbor

7.1.1 GeneHarbor Company Information

7.1.2 GeneHarbor Introduction and Business Overview

7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Offerings

7.1.5 GeneHarbor Recent Development

7.2 Herbalmax

7.2.1 Herbalmax Company Information

7.2.2 Herbalmax Introduction and Business Overview

7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Offerings

7.2.5 Herbalmax Recent Development

7.3 Genex Formulas

7.3.1 Genex Formulas Company Information

7.3.2 Genex Formulas Introduction and Business Overview

7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Offerings

7.3.5 Genex Formulas Recent Development

7.4 Mirailab Bioscience

7.4.1 Mirailab Bioscience Company Information

7.4.2 Mirailab Bioscience Introduction and Business Overview

7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Offerings

7.4.5 Mirailab Bioscience Recent Development

7.5 Maac10 Formulas

7.5.1 Maac10 Formulas Company Information

7.5.2 Maac10 Formulas Introduction and Business Overview

7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Offerings

7.5.5 Maac10 Formulas Recent Development

7.6 EffePharm

7.6.1 EffePharm Company Information

7.6.2 EffePharm Introduction and Business Overview

7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Offerings

7.6.5 EffePharm Recent Development

7.7 Bontac

7.7.1 Bontac Company Information

7.7.2 Bontac Introduction and Business Overview

7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Product Offerings

7.7.5 Bontac Recent Development

7.8 CELFULL

7.8.1 CELFULL Company Information

7.8.2 CELFULL Introduction and Business Overview

7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Offerings

7.8.5 CELFULL Recent Development

7.9 Kingdomway

7.9.1 Kingdomway Company Information

7.9.2 Kingdomway Introduction and Business Overview

7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Product Offerings

7.9.5 Kingdomway Recent Development

7.10 ABA Chemical

7.10.1 ABA Chemical Company Information

7.10.2 ABA Chemical Introduction and Business Overview

7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Product Offerings

7.10.5 ABA Chemical Recent Development

8 Industry Chain Analysis

8.1 Nicotinamide Mononucleotide (NMN) Industrial Chain

8.2 Nicotinamide Mononucleotide (NMN) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Nicotinamide Mononucleotide (NMN) Sales Model

8.5.2 Sales Channel

8.5.3 Nicotinamide Mononucleotide (NMN) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Nicotinamide Mononucleotide (NMN) Market Trends

Table 2. Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity

Table 3. Nicotinamide Mononucleotide (NMN) Market Challenges

Table 4. Nicotinamide Mononucleotide (NMN) Market Restraints

Table 5. Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2020-2025)

Table 7. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company (2020-2025) & (Tons)

Table 8. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Nicotinamide Mononucleotide (NMN) Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters

Table 11. Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Nicotinamide Mononucleotide (NMN)

Table 13. Global Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2020-2025)

Table 20. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Type (2026-2031)

Table 21. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2020-2025) & (Tons)

Table 23. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2026-2031) & (Tons)

Table 24. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Nicotinamide Mononucleotide (NMN) Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2020-2025)

Table 32. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Value by Application (2026-2031)

Table 33. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)

Table 34. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2020-2025) & (Tons)

Table 35. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2026-2031) & (Tons)

Table 36. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Nicotinamide Mononucleotide (NMN) Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Nicotinamide Mononucleotide (NMN) Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Nicotinamide Mononucleotide (NMN) Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2020-2025) & (%)

Table 44. Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2026-2031) & (%)

Table 45. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (Tons): 2020 VS 2024 VS 2031

Table 46. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2020-2025) & (Tons)

Table 47. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2026-2031) & (Tons)

Table 48. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2020-2025) & (%)

Table 49. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2026-2031) & (%)

Table 50. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, (2020-2025) & (Tons)

Table 56. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, (2026-2031) & (Tons)

Table 57. GeneHarbor Company Information

Table 58. GeneHarbor Introduction and Business Overview

Table 59. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. GeneHarbor Nicotinamide Mononucleotide (NMN) Product Offerings

Table 61. GeneHarbor Recent Development

Table 62. Herbalmax Company Information

Table 63. Herbalmax Introduction and Business Overview

Table 64. Herbalmax Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. Herbalmax Nicotinamide Mononucleotide (NMN) Product Offerings

Table 66. Herbalmax Recent Development

Table 67. Genex Formulas Company Information

Table 68. Genex Formulas Introduction and Business Overview

Table 69. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. Genex Formulas Nicotinamide Mononucleotide (NMN) Product Offerings

Table 71. Genex Formulas Recent Development

Table 72. Mirailab Bioscience Company Information

Table 73. Mirailab Bioscience Introduction and Business Overview

Table 74. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Offerings

Table 76. Mirailab Bioscience Recent Development

Table 77. Maac10 Formulas Company Information

Table 78. Maac10 Formulas Introduction and Business Overview

Table 79. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Offerings

Table 81. Maac10 Formulas Recent Development

Table 82. EffePharm Company Information

Table 83. EffePharm Introduction and Business Overview

Table 84. EffePharm Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. EffePharm Nicotinamide Mononucleotide (NMN) Product Offerings

Table 86. EffePharm Recent Development

Table 87. Bontac Company Information

Table 88. Bontac Introduction and Business Overview

Table 89. Bontac Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. Bontac Nicotinamide Mononucleotide (NMN) Product Offerings

Table 91. Bontac Recent Development

Table 92. CELFULL Company Information

Table 93. CELFULL Introduction and Business Overview

Table 94. CELFULL Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. CELFULL Nicotinamide Mononucleotide (NMN) Product Offerings

Table 96. CELFULL Recent Development

Table 97. Kingdomway Company Information

Table 98. Kingdomway Introduction and Business Overview

Table 99. Kingdomway Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. Kingdomway Nicotinamide Mononucleotide (NMN) Product Offerings

Table 101. Kingdomway Recent Development

Table 102. ABA Chemical Company Information

Table 103. ABA Chemical Introduction and Business Overview

Table 104. ABA Chemical Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. ABA Chemical Nicotinamide Mononucleotide (NMN) Product Offerings

Table 106. ABA Chemical Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Nicotinamide Mononucleotide (NMN) Downstream Customers

Table 110. Nicotinamide Mononucleotide (NMN) Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Nicotinamide Mononucleotide (NMN) Product Picture

Figure 2. Global Nicotinamide Mononucleotide (NMN) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Nicotinamide Mononucleotide (NMN) Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Nicotinamide Mononucleotide (NMN) Sales Volume (2020-2031) & (Tons)

Figure 5. Global Nicotinamide Mononucleotide (NMN) Sales Price (2020-2031) & (US$/Kg)

Figure 6. Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 7. Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2024) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Nicotinamide Mononucleotide (NMN) Revenue in 2024

Figure 10. Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Content ≥98% Picture

Figure 12. Content ＜98% Picture

Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)

Figure 16. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Nicotinamide Mononucleotide (NMN) Price by Type (2020-2031) & (US$/Kg)

Figure 18. Product Picture of Health Care Products

Figure 19. Product Picture of Cosmetics

Figure 20. Product Picture of Others

Figure 21. Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)

Figure 24. Global Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Nicotinamide Mononucleotide (NMN) Price by Application (2020-2031) & (US$/Kg)

Figure 26. North America Nicotinamide Mononucleotide (NMN) Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume (%), (2020-2031)

Figure 38. United States Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 44. China Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 46. China Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 56. India Nicotinamide Mononucleotide (NMN) Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031

Figure 58. India Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2024 VS 2031

Figure 59. Nicotinamide Mononucleotide (NMN) Industrial Chain

Figure 60. Nicotinamide Mononucleotide (NMN) Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Nicotinamide Mononucleotide (NMN) in 2031? zhanKai

The global market size of Nicotinamide Mononucleotide (NMN) in 2031 was 992 Million USD.

What is the annual compound growth rate of the global Nicotinamide Mononucleotide (NMN) market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Nicotinamide Mononucleotide (NMN) in 2025? shouQi

Which companies rank high in the global Nicotinamide Mononucleotide (NMN) market? shouQi

Related Reports

Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 190 million in 2025 to US$ 382 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-01
Pages: 156
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Mononucleotide (NMN) market size was US$ 190 million in 2025 and is forecast to reach a readjusted size of US$ 382 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-08-01
Pages: 140
USD 4250.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global Nicotinamide Mononucleotide (NMN) market was valued at US$ 190 million in 2025 and is anticipated to reach US$ 382 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 144
USD 2900.00
(Single User License)
Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 190 million in 2025 and is projected to reach US$ 382 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-08-01
Pages: 137
USD 3950.00
(Single User License)
Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 110
USD 3950.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 144
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 468 million in 2025 to US$ 992 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period.
Published Date: 2025-04-02
Pages: 141
USD 4900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published Date: 2025-04-02
Pages: 89
USD 2900.00
(Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published Date: 2024-12-20
Pages: 146
USD 4900.00
(Single User License)

Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 190 million in 2025 to US$ 382 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-01
Pages: 156
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nicotinamide Mononucleotide (NMN) market size was US$ 190 million in 2025 and is forecast to reach a readjusted size of US$ 382 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-08-01
Pages: 140
USD 4250.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2026
The global Nicotinamide Mononucleotide (NMN) market was valued at US$ 190 million in 2025 and is anticipated to reach US$ 382 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-08-01
Pages: 144
USD 2900.00 (Single User License)
Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 190 million in 2025 and is projected to reach US$ 382 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-08-01
Pages: 137
USD 3950.00 (Single User License)
Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 110
USD 3950.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 144
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2031
The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 468 million in 2025 to US$ 992 million by 2031, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period.
Published: 2025-04-02
Pages: 141
USD 4900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published: 2025-04-02
Pages: 89
USD 2900.00 (Single User License)
Global Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published: 2024-12-20
Pages: 146
USD 4900.00 (Single User License)